Medical Device | December 23, 2021
U.S. FDA grants De Novo Clearance for Philips IVC filter removal laser sheath
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
Philips’s CavaClear is intended to safely ablate tissue to remove embedded IVC filters
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
The first clinical trial is expected to commence in early 2022 both in Europe and the US
When used alongside rehabilitative exercise, this device may offer benefit to those who have lost function in their upper limbs due to ischemic stroke
The aim is to create new genomics solutions that could combat cancer and advance market access
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
